Φορτώνει......
Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting
This article provides new insight on landiolol, an ultra-short acting injectable betablocker, recently approved in Europe, with regard to its pharmacokinetic and pharmacodynamic profile, along with its first experience in Caucasian healthy volunteers and patients with atrial fibrillation. Landiolol...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Eur Heart J Suppl |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5909771/ https://ncbi.nlm.nih.gov/pubmed/30188959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/sux037 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|